Hypothesis

Circadian disruption accelerates the age‑dependent loss of calbindin‑D28k in cholinergic basal forebrain neurons by suppressing BMAL1/CLOCK‑driven transcription of the calbindin promoter, leading to prolonged intracellular calcium elevations and selective neurodegeneration. Restoring circadian rhythms—via timed light exposure, melatonin administration, or pharmacologic enhancement of BMAL1 activity—will preserve calbindin expression, normalize calcium recovery kinetics, and prevent tangle formation in aging brains.

Mechanistic Rationale

• Transcriptional control: BMAL1 and CLOCK heterodimers bind E‑box elements in the calb1 (calbindin‑D28k) promoter, recruiting co‑activators such as p300/CBP that maintain histone H3K27ac marks and an open chromatin state【4】. Loss of BMAL1 rhythmicity reduces this acetylation, permitting HDAC‑mediated deacetylation and increased promoter methylation, which we predict diminishes calbindin mRNA and protein levels.
• Calcium buffering link: Calbindin‑D28k buffers cytosolic Ca²⁺, shaping the decay kinetics of glutamate‑evoked calcium transients【3】. When calbindin declines, astrocytes and neurons exhibit slower ER calcium reuptake and elevated basal Ca²⁺, a state that feeds back to destabilize the molecular clock via CaMKII‑mediated phosphorylation of PER proteins.
• Reciprocal vulnerability: Cholinergic basal forebrain neurons that lose calbindin during aging are precisely those that develop tau pathology in Alzheimer’s disease, while calbindin‑positive neurons resist tangle formation【2】. This suggests that calcium dysregulation is not merely a byproduct but a driver of neurodegeneration in this population.
• Interventional precedent: Caloric restriction prevents age‑related calcium buffering deficits in these neurons【7】, demonstrating that systemic interventions can modulate the phenotype. Circadian entrainment offers a potentially more tractable lever because it directly targets the transcriptional machinery that governs calbindin expression.

Testable Predictions

1. Expression: In 24‑month-old mice housed under constant light (circadian disruption), calbindin‑D28k mRNA and protein levels in the basal forebrain will be reduced by ≥40 % compared with age‑matched controls on a 12:12 light‑dark cycle. Rescue with timed melatonin administration (administered at ZT12) will restore calbindin to ≥80 % of youthful levels.
2. Calcium kinetics: Primary basal forebrain neurons isolated from disrupted mice will show a glutamate‑evoked calcium decay time constant (τ) ≥4.5‑fold longer than controls, mirroring the aged phenotype【3】. Circadian restoration will normalize τ to ≤1.5‑fold of young neurons.
3. Neurodegeneration: Disrupted mice will exhibit a ≥2‑fold increase in phospho‑tau immunoreactivity and neuronal loss in the basal forebrain after 6 months, whereas melatonin‑treated disrupted mice will show pathology indistinguishable from light‑dark controls.
4. Mechanistic validation: Chromatin immunoprecipitation (ChIP) from basal forebrain tissue will reveal reduced BMAL1 occupancy and H3K27ac at the calb1 promoter under constant light; melatonin treatment will restore both BMAL1 binding and acetylation.

Experimental Design (outline)

• Animals: Young (3 mo), aged control (24 mo, 12:12 LD), aged disrupted (24 mo, constant light), aged disrupted + melatonin (24 mo, constant light + melatonin ZT12).
• Readouts: qPCR and Western blot for calbindin; calcium imaging with Fluo‑4 AM after glutamate challenge; immunohistochemistry for AT8 phospho‑tau and NeuN; ChIP‑qPCR for BMAL1 and H3K27ac at the calb1 promoter.
• Statistical plan: Two‑way ANOVA (age × lighting) with post‑hoc Tukey; significance set at p < 0.05.

Falsifiability

If circadian disruption does not alter calbindin expression, calcium recovery kinetics, or tau pathology in basal forebrain neurons, or if melatonin fails to rescue these measures despite restoring behavioral rhythms, the hypothesis would be falsified. Conversely, a positive outcome would support the notion that the circadian system acts as a transcriptional firewall preserving calcium‑buffering capacity and thereby protecting against excitotoxic aging.